MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
Digital Strategies for Medical Affairs

CyberThink in Action: 3 Digital Strategies for Medical Affairs

Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Patient Advocacy

Shaping the Future of Patient Advocacy: Anticipating Key Trends and Developments by 2030

Patient advocacy stands at the forefront of patient-centered care, dedicated to enhancing treatment outcomes and...

Learn more ABOUT our company.